Three-dimensional fibrous PLGA/HAp composite scaffold for BMP-2 delivery
- PMID: 17570710
- DOI: 10.1002/bit.21517
Three-dimensional fibrous PLGA/HAp composite scaffold for BMP-2 delivery
Abstract
A protein loaded three-dimensional scaffold can be used for protein delivery and bone tissue regeneration. The main objective of this project was to develop recombinant human bone morphogenetic protein-2 (rhBMP-2) loaded poly(D,L-lactide-co-glycolide)/hydroxylapatite (PLGA/HAp) composite fibrous scaffolds through a promising fabrication technique, electrospinning. In vitro release of BMP-2 from these scaffolds, and the attachment ability and viability of marrow derived messenchymal stem cells (MSCs) in the presence of the scaffolds were investigated. The PLGA/HAp composite scaffolds developed in this study exhibit good morphology and it was observed that HAp nanoparticles were homogeneously dispersed inside PLGA matrix within the scaffold. The composite scaffolds allowed sustained (2-8 weeks) release of BMP-2 whose release rate was accelerated with increasing HAp content. It was also shown that BMP-2 protein successfully maintained its integrity and natural conformations after undergoing the process of electrospinning. Cell culture experiments showed that the encapsulation of HAp could enhance cell attachment to scaffolds and lower cytotoxicity.
(c) 2007 Wiley Periodicals, Inc.
Similar articles
-
Optimized bone regeneration based on sustained release from three-dimensional fibrous PLGA/HAp composite scaffolds loaded with BMP-2.Biotechnol Bioeng. 2008 Mar 1;99(4):996-1006. doi: 10.1002/bit.21648. Biotechnol Bioeng. 2008. PMID: 17879301
-
Fabrication and characterization of PLGA/HAp composite scaffolds for delivery of BMP-2 plasmid DNA.J Control Release. 2007 Jul 16;120(1-2):111-21. doi: 10.1016/j.jconrel.2007.03.018. Epub 2007 Apr 1. J Control Release. 2007. PMID: 17512077
-
Enhancement of ectopic bone formation by bone morphogenetic protein-2 released from a heparin-conjugated poly(L-lactic-co-glycolic acid) scaffold.Biomaterials. 2007 Jun;28(17):2763-71. doi: 10.1016/j.biomaterials.2007.02.023. Epub 2007 Mar 12. Biomaterials. 2007. PMID: 17350678
-
Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives.J Control Release. 2008 Feb 11;125(3):193-209. doi: 10.1016/j.jconrel.2007.09.013. Epub 2007 Oct 22. J Control Release. 2008. PMID: 18083265 Review.
-
[Translational research using BMP family proteins].Nihon Rinsho. 2005 Oct;63 Suppl 10:458-62. Nihon Rinsho. 2005. PMID: 16279682 Review. Japanese. No abstract available.
Cited by
-
Electrospun nanofibers for regenerative medicine.Adv Healthc Mater. 2012 Jan 11;1(1):10-25. doi: 10.1002/adhm.201100021. Epub 2011 Dec 16. Adv Healthc Mater. 2012. PMID: 23184683 Free PMC article. Review.
-
Teriparatide therapy and beta-tricalcium phosphate enhance scaffold reconstruction of mouse femoral defects.Tissue Eng Part A. 2011 Feb;17(3-4):389-98. doi: 10.1089/ten.TEA.2010.0115. Epub 2010 Oct 29. Tissue Eng Part A. 2011. PMID: 20807012 Free PMC article.
-
The biological applications of DNA nanomaterials: current challenges and future directions.Signal Transduct Target Ther. 2021 Oct 8;6(1):351. doi: 10.1038/s41392-021-00727-9. Signal Transduct Target Ther. 2021. PMID: 34620843 Free PMC article. Review.
-
Electrospun nanofibrous materials for tissue engineering and drug delivery.Sci Technol Adv Mater. 2010 Mar 18;11(1):014108. doi: 10.1088/1468-6996/11/1/014108. eCollection 2010 Feb. Sci Technol Adv Mater. 2010. PMID: 27877323 Free PMC article. Review.
-
Electrospun Biomimetic Nanofibrous Scaffolds: A Promising Prospect for Bone Tissue Engineering and Regenerative Medicine.Int J Mol Sci. 2022 Aug 16;23(16):9206. doi: 10.3390/ijms23169206. Int J Mol Sci. 2022. PMID: 36012473 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources